Endocrine News The Leading Magazine for Endocrinologists
- Pharmaceutical Phenomenapor Mark Newman on noviembre 20, 2024 at 1:46 pm
Recent studies shed light on the safety and efficacy of diabetes medications GLP-1 receptor agonists, SGLT2 inhibitors, and DPP4 inhibitors were all scrutinized in new research presented at ENDO 2024. While most of the results were good news for the impact of medications for people with type 2 diabetes, clinicians prescribing these medications should be... The post Pharmaceutical Phenomena appeared first on Endocrine News.
- Beating Prediabetespor Mark Newman on noviembre 14, 2024 at 2:57 pm
New research explores the impact of prediabetes on a Mexican population. According to a study presented at ENDO 2024, prediabetes increases the risk of dying before the age of 75, particularly due to heart disease, kidney disease, and acute diabetic complications in Mexican populations. The study’s author, Carlos A. Fermín-Martínez, MD, discusses his findings and... The post Beating Prediabetes appeared first on Endocrine News.
- HDL Quality, Not Quantity, Contributes to the First Sign of Alzheimer’s Disease in Womenpor Derek Bagley on noviembre 13, 2024 at 5:43 pm
Higher levels of HDL-C—known as the “good cholesterol”—have been shown to correlate with heightened risk for Alzheimer’s disease, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Once women reach the menopause transition, it’s a matter of the quality, rather than quantity, of the total cholesterol carried by HDL particles circulating in a... The post HDL Quality, Not Quantity, Contributes to the First Sign of Alzheimer’s Disease in Women appeared first on Endocrine News.
- All the Rage: Combatting Counterfeit Weight-Loss and Diabetes Drugspor Mark Newman on noviembre 13, 2024 at 4:44 pm
As online ads abound for diabetes and obesity medications, endocrinologists should be prepared to talk to patients who may be attracted to GLP-1 drug lookalikes and supplements from questionable sources. GLP-1 agonists are a cultural phenomenon. Celebrities and social media influencers hyping the drugs’ weight-loss success has led to demand outstripping supply, resulting in shortages... The post All the Rage: Combatting Counterfeit Weight-Loss and Diabetes Drugs appeared first on Endocrine News.
- Do Vitamin D Supplements Lower Blood Pressure in Older People with Obesity?por Mark Newman on noviembre 12, 2024 at 2:00 pm
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society. The IOM recommends 600 International Units (IU) per day. Vitamin D deficiency is common... The post Do Vitamin D Supplements Lower Blood Pressure in Older People with Obesity? appeared first on Endocrine News.